Visual analogue scales for pain assessment in Alzheimer's disease

Citation
Eja. Scherder et A. Bouma, Visual analogue scales for pain assessment in Alzheimer's disease, GERONTOLOGY, 46(1), 2000, pp. 47-53
Citations number
25
Categorie Soggetti
Medical Research General Topics
Journal title
GERONTOLOGY
ISSN journal
0304324X → ACNP
Volume
46
Issue
1
Year of publication
2000
Pages
47 - 53
Database
ISI
SICI code
0304-324X(200001/02)46:1<47:VASFPA>2.0.ZU;2-6
Abstract
Background: In earlier studies, pain assessment in patients with Alzheimer' s disease (AD) was conducted by interview, for which reliability is questio nable considering the decline in expressive and receptive language abilitie s in AD. As similar language problems occur in young children, the reliabil ity of pain assessment in this latter population is increased by employing visual analogue scales. Objective: By employing visual analogue scales, the current study investigated whether (1) nondemented elderly persons and AD patients comprehend the purpose of the scales and (2) AD patients, compared to nondemented elderly persons, report suffering less pain intensity and p ain affect. Methods: Three visual analogue scales, i.e. the Colored Analogu e Scale (CAS), the Faces Pain Scale (FPS), and the Facial Affective Scale ( FAS) were administered to patients in an early and midstage of AD and to no ndemented elderly persons. Results: The results show that the percentage of subjects who comprehended the GAS, FAS and FPS was for the nondemented eld erly persons 100, 75 and 100%, respectively, for the early AD group 100, 50 and 60%, respectively, and for the midstage AD group 80, 20 and 30%, respe ctively. Furthermore, elderly persons without dementia reported experiencin g more intense pain and pain affect than the early and midstage AD group. I nterestingly, the early and midstage AD patients did not differ in reportin g pain affect. Conclusion: Visual analogue scales may improve pain assessme nt in those AD patients who fully comprehend the meaning of the scales. As only the minority of midstage AD patients understood the purpose of the FAS and FPS, the search for tools, particularly to assess pain affect in this population, must continue. Copyright (C) 2000 S.Karger AG, Basel.